Kelleher Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.88K | Hold |
251
| – | – | ﹤0.01% | 607 |
|
|
2025
Q4 | $3.91K | Hold |
251
| – | – | ﹤0.01% | 635 |
|
|
2025
Q3 | $3.67K | Buy |
+251
| New | +$3.73K | ﹤0.01% | 568 |
|
|
2024
Q3 | – | Sell |
-23,063
| Closed | -$298K | – | 123 |
|
|
2024
Q2 | $298K | Hold |
23,063
| – | – | 0.12% | 93 |
|
|
2024
Q1 | $320K | Hold |
23,063
| – | – | 0.13% | 93 |
|
|
2023
Q4 | $329K | Sell |
23,063
-528
| -2% | -$7.49K | 0.15% | 79 |
|
|
2023
Q3 | $365K | Sell |
23,591
-49
| -0.2% | -$759 | 0.19% | 71 |
|
|
2023
Q2 | $371K | Sell |
23,640
-1
| -0% | -$16 | 0.21% | 76 |
|
|
2023
Q1 | $390K | Buy |
23,641
+45
| +0.2% | +$717 | 0.26% | 72 |
|
|
2022
Q4 | $368K | Buy |
23,596
+309
| +1% | +$4.32K | 0.28% | 63 |
|
|
2022
Q3 | $302K | Buy |
23,287
+438
| +2% | +$6.09K | 0.22% | 79 |
|
|
2022
Q2 | $320K | Buy |
22,849
+210
| +0.9% | +$3K | 0.14% | 98 |
|
|
2022
Q1 | $324K | Sell |
22,639
-3,531
| -13% | -$51.8K | 0.18% | 88 |
|
|
2021
Q4 | $356K | Sell |
26,170
-9,780
| -27% | -$137K | 0.19% | 82 |
|
|
2021
Q3 | $588K | Buy |
35,950
+16,691
| +87% | +$280K | 0.26% | 88 |
|
|
2021
Q2 | $324K | Hold |
19,259
| – | – | 0.18% | 89 |
|
|
2021
Q1 | $351K | Buy |
19,259
+5,695
| +42% | +$102K | 0.23% | 75 |
|
|
2020
Q4 | $246K | Sell |
13,564
-5
| -0% | -$88 | 0.18% | 88 |
|
|
2020
Q3 | $242K | Sell |
13,569
-1,881
| -12% | -$34.3K | 0.2% | 80 |
|
|
2020
Q2 | $277K | Sell |
15,450
-251
| -2% | -$4.51K | 0.27% | 73 |
|
|
2020
Q1 | $238K | Sell |
15,701
-1,080
| -6% | -$19.6K | 0.28% | 71 |
|
|
2019
Q4 | $330K | Sell |
16,781
-204
| -1% | -$3.9K | 0.33% | 66 |
|
|
2019
Q3 | $292K | Sell |
16,985
-951
| -5% | -$16.4K | 0.36% | 66 |
|
|
2019
Q2 | $317K | Buy |
+17,936
| New | +$326K | 0.39% | 63 |
|
Other funds holding TAK
BIP
